594 related articles for article (PubMed ID: 26433051)
1. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
[TBL] [Abstract][Full Text] [Related]
2. A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.
Hu H; Voss J; Zhang G; Buchy P; Zuo T; Wang L; Wang F; Zhou F; Wang G; Tsai C; Calder L; Gamblin SJ; Zhang L; Deubel V; Zhou B; Skehel JJ; Zhou P
J Virol; 2012 Mar; 86(6):2978-89. PubMed ID: 22238297
[TBL] [Abstract][Full Text] [Related]
3. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
Tan Y; Ng Q; Jia Q; Kwang J; He F
J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
[TBL] [Abstract][Full Text] [Related]
4. A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin.
Zhu X; Guo YH; Jiang T; Wang YD; Chan KH; Li XF; Yu W; McBride R; Paulson JC; Yuen KY; Qin CF; Che XY; Wilson IA
J Virol; 2013 Dec; 87(23):12619-35. PubMed ID: 24049169
[TBL] [Abstract][Full Text] [Related]
5. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
[TBL] [Abstract][Full Text] [Related]
6. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
[TBL] [Abstract][Full Text] [Related]
7. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.
Velkov T; Ong C; Baker MA; Kim H; Li J; Nation RL; Huang JX; Cooper MA; Rockman S
Mol Immunol; 2013 Dec; 56(4):705-19. PubMed ID: 23933511
[TBL] [Abstract][Full Text] [Related]
8. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
[TBL] [Abstract][Full Text] [Related]
9. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
Kaverin NV; Rudneva IA; Govorkova EA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Krylov PS; Webster RG
J Virol; 2007 Dec; 81(23):12911-7. PubMed ID: 17881439
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
Ohkura T; Kikuchi Y; Kono N; Itamura S; Komase K; Momose F; Morikawa Y
Biochem Biophys Res Commun; 2012 Feb; 418(1):38-43. PubMed ID: 22226969
[TBL] [Abstract][Full Text] [Related]
12. A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.
Panaampon J; Ngaosuwankul N; Suptawiwat O; Noisumdaeng P; Sangsiriwut K; Siridechadilok B; Lerdsamran H; Auewarakul P; Pooruk P; Puthavathana P
PLoS One; 2012; 7(5):e36318. PubMed ID: 22563489
[TBL] [Abstract][Full Text] [Related]
13. Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus.
Rudneva IA; Kushch AA; Masalova OV; Timofeeva TA; Klimova RR; Shilov AA; Ignatieva AV; Krylov PS; Kaverin NV
Viral Immunol; 2010 Apr; 23(2):181-7. PubMed ID: 20373998
[TBL] [Abstract][Full Text] [Related]
14. Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.
He F; Prabakaran M; Rajesh Kumar S; Tan Y; Kwang J
Antiviral Res; 2014 May; 105():143-51. PubMed ID: 24637255
[TBL] [Abstract][Full Text] [Related]
15. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
[TBL] [Abstract][Full Text] [Related]
16. Prime-Boost Vaccination With a Novel Hemagglutinin Protein Produced in Bacteria Induces Neutralizing Antibody Responses Against H5-Subtype Influenza Viruses in Commercial Chickens.
Sączyńska V; Romanik-Chruścielewska A; Florys K; Cecuda-Adamczewska V; Łukasiewicz N; Sokołowska I; Kęsik-Brodacka M; Płucienniczak G
Front Immunol; 2019; 10():2006. PubMed ID: 31552018
[TBL] [Abstract][Full Text] [Related]
17. Subclade 2.2.1-Specific Human Monoclonal Antibodies That Recognize an Epitope in Antigenic Site A of Influenza A(H5) Virus HA Detected between 2015 and 2018.
Okuda M; Yamayoshi S; Uraki R; Ito M; Hamabata T; Kawaoka Y
Viruses; 2019 Apr; 11(4):. PubMed ID: 30987023
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation and an amino acid insertion in the head of hemagglutinin independently affect the antigenic properties of H5N1 avian influenza viruses.
Gu C; Zeng X; Song Y; Li Y; Liu L; Kawaoka Y; Zhao D; Chen H
Sci China Life Sci; 2019 Jan; 62(1):76-83. PubMed ID: 30515728
[TBL] [Abstract][Full Text] [Related]
19. DNA prime and virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 hemagglutinin.
Wang G; Zhou F; Buchy P; Zuo T; Hu H; Liu J; Song Y; Ding H; Tsai C; Chen Z; Zhang L; Deubel V; Zhou P
J Infect Dis; 2014 Mar; 209(5):676-85. PubMed ID: 23911711
[TBL] [Abstract][Full Text] [Related]
20. Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses.
Nuñez IA; Ross TM
Vaccine; 2020 Jan; 38(4):830-839. PubMed ID: 31733946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
